Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment

Despite the rapid developments and advancements to improve treatments, Breast cancer remains one of the deadliest health challenges and the most frequently diagnosed tumor. One of the major problems with treatment is the unique difference that each cancerous cell exhibits. As a result, treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinnusi, Precious A, Olubode, Samuel O, Adebesin, Ayomide O, Nana, Toluwani A, Shodehinde, Sidiqat A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536107/
https://www.ncbi.nlm.nih.gov/pubmed/36213305
http://dx.doi.org/10.1177/11769351221127862

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536107/
https://www.ncbi.nlm.nih.gov/pubmed/36213305
http://dx.doi.org/10.1177/11769351221127862

Ejemplares similares